Skip to main content

IndiGo Q2 loss widens to Rs 1,194.8 crore on YoY basis, but beats estimates

EBITDAR came at 408.5 crore, up 59.3 percent YoY from Rs 256.4 crore. CNBC-TV18 poll's estimate for EBITDAR was Rs 511 crore loss.

Airline company InterGlobe Aviation (IndiGo) on October 29 said its loss widened to Rs 1,194.8 crore in Q2 FY21, higher than the loss of Rs 1,062 crore posted in the corresponding quarter of the previous financial year.

However, the number was better-than-expected as a CNBC-TV18 poll had estimated the loss to the tune of Rs 1,897 crore. It helped that the company's total expenses fell 55.9 percent YoY to Rs 4,224.1 crore in Q2FY21 from Rs 9,571.6 crore in Q2FY20.

The company's revenue for the said quarter came at Rs 2,741 crore against Rs 8,105.2 crore. This, too, was above the CNBC-TV18 poll of Rs 2,678 crore.

EBITDAR, or earnings before interest, tax, depreciation, amortisation and rent, came at 408.5 crore, up 59.3 percent YoY from Rs 256.4 crore. CNBC-TV18 poll's estimate for EBITDAR was Rs 511 crore loss.





EBITDAR margin stood at 14.9 percent, up 11.7 pts YoY from 3.2 percent in Q2FY20. Load factor for the quarter stood at 65.1 percent, down 18.5 pts YoY from 83.5 percent.

Total debt increased 28.1 percent YoY to Rs 25,419.4 crore. It had a total cash balance of Rs 17,931 crore, a slight reduction from Rs 18,449.8 crore in the first quarter.

"We are pleased that we are slowly but surely stair-stepping our way back to normal capacity," CEO Ronojoy Dutta said. "While we are very much focused on managing the crisis of the present, we are also reimagining the promise of the future. Once we are back at to  100 percent capacity, we will have lower unit costs, a stronger product, a more efficient fleet and a robust network. We are impatient for the arrival of the future," he added.

The showing in the second quarter was a marked improvement from the first, where it reported a net loss of Rs 2,844.3 crore for the quarter ended June 2020 as coronavirus-led lockdown impacted operations.

Domestic flights had resumed in May, and since then the cap on capacity utilisation has been raised to 60 percent. A report by CAPA India, released on Thursday, said that capacity utilisation on an average stood at 35 percent on average, as on September 30.

Sharing its outlook for the third quarter, IndiGo said, "Third quarter fiscal 2021 capacity in ASKs is expected to be around 60 percent of third quarter fiscal 2020 capacity."

The airline's fleet increased to 282 aircraft, as compared to 274 in the first quarter. The increase came in the form of additional Airbus A320neo, which increased to 116, from 108. At the same time, the budget carrier reduced the older generation A320Ceo from 123 ,to 117.


Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more